Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up To Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan

Go back to Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up To Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan
RITE AID CORPORATION (NYSE: RAD) Delayed: 0.65 --0 (-0%)
Previous Close $0.65    52 Week High $8.30 
Open $11.16    52 Week Low $6.33 
Day High $0.65    P/E 1.91 
Day Low $0.65    EPS $0.34 
Volume 63,391       

(NASDAQ: RADX) Delayed: 2.12 +0.04 (1.92%)
Previous Close $2.08    52 Week High
Open $2.08    52 Week Low
Day High $2.30    P/E N/A 
Day Low $2.06    EPS
Volume 27,663